Patient info Search Menu

Lotriderm cream – Summary of Product Characteristics (SmPC) for healthcare professionals

The Summary of Product Characteristics (SmPC) is written for healthcare professionals. Patients will find plain advice in the patient information leaflet: how to take, side effects, other medicines, pregnancy and breast-feeding.

Status:
Prescription only (POM) Key facts
Medicine strength:
640 microgram/gram + 10 mg/gram
Contains active substances:

Summary of Product Characteristics (SmPC) - Lotriderm cream

1. NAME OF THE MEDICINAL PRODUCT

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

3. PHARMACEUTICAL FORM

4. CLINICAL PARTICULARS

4.1. Therapeutic indications

4.2. Posology and method of administration

4.3. Contraindications

4.4. Special warnings and precautions for use

4.5. Interactions with other medicinal products and other forms of interaction

4.6. Pregnancy and lactation

4.7. Effects on ability to drive and use machines

4.8. Undesirable effects

4.9. Overdose

5. PHARMACOLOGICAL PROPERTIES

5.1. Pharmacodynamic properties

5.2. Pharmacokinetic properties

5.3. Preclinical safety data

6. PHARMACEUTICAL PARTICULARS

6.1. List of excipients

6.2. Incompatibilities

6.3. Shelf life

6.4. Special precautions for storage

6.5. Nature and contents of container

6.6. Instruction for use and handling (, and disposal)

No Data Held

Administrative Data

7. MARKETING AUTHORISATION HOLDER

8. MARKETING AUTHORISATION NUMBER

9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

10. DATE OF REVISION OF THE TEXT

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 16369/0494

MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Lotriderm cream

What these facts mean

Prescription needed?? Yes, prescription-only medicine (POM)
Active substances? Betamethasone, Clotrimazole
Strength? 640 microgram/gram + 10 mg/gram
Pharmaceutical form? Cutaneous cream
How is it taken? Cutaneous
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)?
  1. D Dermatologicals
    1. D07 Corticosteroids, dermatological preparations
      1. D07C Corticosteroids, combinations with antibiotics
        1. D07CC Corticosteroids, potent, combinations with antibiotics
          1. D07CC01 betamethasone and antibiotics
Marketing authorisation? PLPI 15184/1113, PLPI 16369/0494
Codes? BNF 13040000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.